Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws

Drug Alcohol Depend. 2021 Oct 29;229(Pt B):109159. doi: 10.1016/j.drugalcdep.2021.109159. Online ahead of print. ABSTRACT BACKGROUND: Highly-potent cannabis products, e.g., concentrates, entail greater risks of cannabis-related harms than lower-potency products such as plant or flower material. However, little information is available on whether individuals in U.S. states with recreational cannabis laws Read more…

Partage le savoir

Safety and Sourcing of Topical Cannabinoids: Many Questions, Few Answers

J Clin Aesthet Dermatol. 2021 Aug;14(8):49-51. Epub 2021 Aug 1. ABSTRACT BACKGROUND: Topical cannabinoid products are increasingly being recommended and used for a variety of dermatologic conditions. Despite this, safety and efficacy data of topical preparations are lacking, and the differences between topical and oral formulations are not well characterized. Read more…

Partage le savoir

Superlatives in news articles reporting non-FDA approved indications for use of cannabis and cannabis products with a focus on psychiatric disorders: a cross-sectional analysis

J Ment Health. 2021 Nov 28:1-6. doi: 10.1080/09638237.2021.1979492. Online ahead of print. ABSTRACT The exaggerated language used in news articles to describe the benefits of cannabis for conditions without FDA indications may mislead the public and healthcare providers. Thus, this study’s objective was to investigate the use of exaggerated language Read more…

Partage le savoir

Passive exposure to cannabidiol oil does not cause microbiome dysbiosis in larval zebrafish

Curr Res Microb Sci. 2021 Jun 21;2:100045. doi: 10.1016/j.crmicr.2021.100045. eCollection 2021 Dec. ABSTRACT The use of cannabidiol oil derived products has dramatically increased in popularity and is predicted to grow steadily over the next decade. Given its relative stability, cannabidiol is likely to accumulate in the environment and affect aquatic Read more…

Partage le savoir

Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews

Phytother Res. 2021 Nov 29. doi: 10.1002/ptr.7263. Online ahead of print. ABSTRACT The debate on the use of cannabinoids for therapeutic purposes is constantly on the rise. This overview aimed to map the evidence on the therapeutic effects of cannabis derivatives and their synthetic analogs. Systematic reviews (SRs) of randomized Read more…

Partage le savoir

Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series

Integr Cancer Ther. 2021 Jan-Dec;20:15347354211061739. doi: 10.1177/15347354211061739. ABSTRACT BACKGROUND: Chemotherapy-induced peripheral neuropathy is a common and often severe side effect from many chemotherapeutic agents, with limited treatment options. There is no literature on the use of topical cannabinoids for chemotherapy-induced neuropathy. CASE PRESENTATIONS: The current manuscript presents a case series Read more…

Partage le savoir

Cannabis sativa research trends, challenges, and new-age perspectives

iScience. 2021 Nov 1;24(12):103391. doi: 10.1016/j.isci.2021.103391. eCollection 2021 Dec 17. ABSTRACT Cannabis sativa L. has been one of the oldest medicinal plants cultivated for 10,000 years for several agricultural and industrial applications. However, the plant became controversial owing to some psychoactive components that have adverse effects on human health. In Read more…

Partage le savoir

Prevalence and Social Acceptability of Cannabis, Tobacco, and Alcohol Use in Adult Women

Womens Health Rep (New Rochelle). 2021 Oct 4;2(1):452-458. doi: 10.1089/whr.2021.0042. eCollection 2021. ABSTRACT Background: As more US states legalize cannabis use, prevalence of use continues to rise and attitudes toward use are changing. This study examined (1) the relationship between cannabis use and social acceptability of use and (2) how Read more…

Partage le savoir
error: Content is protected !!